News and updates
Evaluation of a single 1.000 mg iron dose as ferric carboxymaltose (FCM) for fat…
Amsterdam, June 15, 2012. Dr Micheal Hedenus of the Haematology Unit of the Sundsval Hospital in Sweden will present promising results on a study on a single iron dose for fatigue treatment in iron deficient women at the 17th Congress of the European Hematology Association in Amsterdam.
How malignant cells in patients with Chronic Lymphocytic Leukemia escape T cell …
Amsterdam, June 15, 2012. Dr Alan Ramsay will present findings of a study in patients with Chronic Lymphocytic Leukemia that will contribute to the design of immunotherapeutic strategies leading to the killing of cancer cells at the 17th Congress of the European Hematology Association in Amsterdam.
Reduction of chemotherapy and PET-guided radiotherapy in advanced-stage Hodgkin …
Amsterdam, June 15, 2012. “Hodgkin lymphoma has become one of the most curable malignancies in adults,” was stated by Dr Andreas Engert, Professor of Hematology at the University Hospital of Cologne in Germany. Results of the German Hodgkin Study Group (GHSG) HD 15 trial are presented at the 17th Congress of the European Hematology Association in Amsterdam.
EMA Issues Call for Expressions of Interest for Drug Safety Studies
The European Medicines Agency (EMA) has launched a new Call for Expressions of Interest for Drug Safety Studies with a view to drawing up a list of potential contractors who may be invited to reply to specific invitations to tender in the future.
Would you sell Peripheral Blood derived Stem Cells?
An article in the New England Journal of Medicine in January entitled ‘Selling Bone Marrow-Flynn v. Holder by Glen Cohen1 reports on a disturbing development in the USA. Cohen reviews a recent judgment by the U.S. Court of Appeals for the Ninth Circuit which held that a ban on selling ‘bone marrow,’ that is part of the National Organ Transplant Act (NOTA) of 1984,2 does not encompass ‘peripheral blood stem cells’. The judgment, according to Cohen, is based on the statutory interpretation of NOTA, not on the plaintiff’s more radical claim that the prohibition on selling bone marrow violates the Equal Protection Clause of the U.S. Constitution.
EHA supports the European Medicines Agency's investigation into risk based quali…
In their Reflection paper on risk based management in clinical trials the European Medicines Agency (EMA) is aiming to describe the concept of risk based quality management in the setting of clinical research.
Report "Haematology and the next European Decade"
EHA and the European Cancer Patient Coalition co-hosted a meeting at the European Parliament in Brussels on August 30-31, 2011.
Horizon 2020: The European Commission proposes the successor to Framework Progra…
On November 30, 2011, the European Commission presented its proposal for Horizon 2020, the financial instrument for research and innovation funding from 2014-2020. The €80 billion Horizon 2020 will replace the current (€51 billion) Framework Programme 7 (FP7).
5th Focus in Paediatric Haematology-Oncology
A very successful 5th 'Focus in Pediatric Haematology-Oncology' course was held from October 23-26 in Sorrento in a small, friendly hotel with excellent facilities on the edge of the beautiful southern end of the Bay of Naples.
Press Release "Crucial Directives must be revised to protect patients' interests…
The current revision of two European Directives that are crucial to successful research into blood-related diseases must ensure the safety of patients and enhance their access to vitally-important treatment.
Press Release: Better funding for research into blood diseases will save more li…
Research into blood-related diseases saves and improves the lives of millions of EU citizens each year, but lack of awareness of this fact means that too often, funding does not feed directly enough into advancing the treatment of patients.
Press Release: “Building the knowledge economy in the world of blood diseases: p…
On the 30th and 31st of August a conference will be hosted in the European Parliament that will demonstrate the leading role hematology will have in securing the future knowledge economy envisaged in the Europe 2020 Strategy.
Dr A van Hylckama Vlieg Announced Winner of the first EHA-ISTH Joint Fellowship
Dr A van Hylckama Vlieg was recently awarded the very first Joint Fellowships of the European Hematology Association (EHA)-International Society on Thrombosis and Haemostasis (ISTH) at the16th Congress of EHA in London, UK.
EHA Awards 2011 at the 16th Congress of EHA in London
At the 16th Congress of EHA in London the EHA Jean Bernard Lifetime Achievement Award will be handed to Professor Bob Löwenberg and the EHA José Carreras Award to Professor Douglas Higgs.
Brussels Declaration on the Recognition of Professional QualificationsThe future…
On March 11, 2011, H-Net met in Brussels. H-Net is the European Network for Harmonisation of Training in Haematology and is funded by a Leonardo da Vinci Grant from the European Commission, DG Education and Culture. The meeting was attended by most of its partnership which includes the European Hematology Association (EHA), the European School of Haematology (ESH), 23 national societies for Haematology in Europe, and the universities of Liverpool and Uppsala.